Table 2

Current definition of complete remission

EBMT criteria,* Bladé et al15 IMWG uniform criteria, Durie et al19 
sCR ND CR plus normal FLC ratio Absence of clonal plasma cells by Immunochemistry or fluorescence 
CR 
  • Absence of M protein in serum and urine by IFX

  • < 5% bone marrow plasma cells

  • No increase of lytic bone lesions

  • Disappearance of soft issue plasmacytomas

 
Same definition 
VGPR ND Serum and urine M protein detectable by IFX but not on electrophoresis or 90% or greater reduction in serum M protein plus urine M-protein < 100 mg per 24 h 
EBMT criteria,* Bladé et al15 IMWG uniform criteria, Durie et al19 
sCR ND CR plus normal FLC ratio Absence of clonal plasma cells by Immunochemistry or fluorescence 
CR 
  • Absence of M protein in serum and urine by IFX

  • < 5% bone marrow plasma cells

  • No increase of lytic bone lesions

  • Disappearance of soft issue plasmacytomas

 
Same definition 
VGPR ND Serum and urine M protein detectable by IFX but not on electrophoresis or 90% or greater reduction in serum M protein plus urine M-protein < 100 mg per 24 h 

sCR indicates stringent CR; ND, not defined; CR, complete response; FLC, free light chain; IFX, immunofixation; and VGPR, very good partial response.

*

Maintained at least 6 weeks.

Two consecutive assessments before any new therapy.

Close Modal

or Create an Account

Close Modal
Close Modal